The standard research protocol is 300 mcg per day, subcutaneous, administered in a fasted state, typically in the morning before food or exercise
Enrolling in drug coverage as soon as you become eligible can also help you avoid having to pay the Medicare Part D late enrollment penalty down the road
Methylcobalamin is used in the treatment of the following diseases: vitamin B12 deficiency pernicious anemia, amyotrophic lateral sclerosis (ALS), peripheral and diabetic neuropathies
They can provide guidance on proper injection technique, site selection, and any additional steps you can take to ensure a positive experience with B12 injections
Elevated dose: 2.5 mL BAC water 15 syringe units (0.15 mL) for a 4.8 mg dose
Always consult with your healthcare provider to determine whether these therapies are right for you